Blood Screening Market Analysis
The global Blood Screening Market, estimated at USD 3.02 billion in 2023, is projected to experience robust growth over the next decade. According to industry forecasts, the market is expected to reach USD 7.37 billion by 2031, growing at a compound annual growth rate (CAGR) of 11.8% from 2024 to 2031.
Blood screening is a critical process in healthcare, ensuring the safety and quality of blood and blood products by detecting infectious agents and other harmful substances. The demand for advanced blood screening technologies is driven by the need for accurate and timely diagnosis to prevent the transmission of infections through blood transfusions.
Get Free Sample Copy of Report: https://www.snsinsider.com/sample-request/3151

KEY MARKET SEGMENTATION
By Product & Service
- Reagents & Kits
- NAT Reagents & Kits
- Enzymes & Polymerases
- Standards & Controls
- Probes & Primers
- Buffers, Nucleotides, and Solutions
- Labelling & Detection Reagents
- ELISA Reagents & Kits
- Immunosorbents
- Controls
- Conjugates
- Substrates
- Sample Diluents & Wash Solutions
- Other Reagents & Kits
- NAT Reagents & Kits
- Instruments
- Rental Purchase
- Outright Purchase
- Software & Services
By Technology
- Nucleic Acid Test
- Transcription-mediated Amplification
- Real-time PCR
- ELISA
- Chemiluminescent Immunoassays
- Fluorescent Immunoassays
- Colorimetric Immunoassays
- Rapid Tests
- Western Blot Assays
- Next-generation Sequencing
By End User
- Blood Banks
- Hospitals
Key drivers of this market growth include:
- Rising Incidence of Infectious Diseases: The increasing prevalence of infectious diseases such as HIV, hepatitis, and Zika virus is driving the demand for comprehensive blood screening tests.
- Advancements in Screening Technologies: Innovations in blood screening technologies, including nucleic acid testing (NAT), enzyme-linked immunosorbent assay (ELISA), and next-generation sequencing (NGS), are enhancing the accuracy and efficiency of screening processes.
- Growing Awareness and Stringent Regulations: Increased awareness about blood safety and stringent regulatory requirements for blood screening are propelling market growth.
- Expansion of Blood Donation and Transfusion Services: The expansion of blood donation and transfusion services worldwide is increasing the demand for effective blood screening solutions.
- Focus on Preventive Healthcare: The growing emphasis on preventive healthcare and early diagnosis is boosting the adoption of blood screening tests as part of routine health check-ups.
The blood screening market’s strong growth trajectory presents significant opportunities for stakeholders, including healthcare providers, diagnostic laboratories, and technology developers, to innovate and expand within this vital sector.
Cardiovascular Information System Market